Methylprednisolone Induce Terminal Differentiation in the U-937 Human Myelomonocytic Leukemia Cells


Ozclmen A. A. , ÇETİN M.

TURKISH JOURNAL OF IMMUNOLOGY, cilt.13, sa.1, ss.10-14, 2008 (ESCI İndekslerine Giren Dergi) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 13 Konu: 1
  • Basım Tarihi: 2008
  • Dergi Adı: TURKISH JOURNAL OF IMMUNOLOGY
  • Sayfa Sayıları: ss.10-14

Özet

Differentiation studies have shown that methylprednisolone have some roles onto the leukemia cell line such as HL-60 and K-562. Methylprednisolone (MP), a steroid compound, binds the nuclear glucocorticoid receptor and regulates the transcription. In this study, differentiation effect of methylprednisolone on human monocytic leukemia (U-937) cell line was investigated for two types of cluster differentiation (CD11b, CD68) markers by using flow cytometry. It was observed that the significant terminal differentiation of U-937 cells occured after treatment with high dose (10-3 M) MP for 24 and 48 hrs. Our data points out that MP is a differentiation inducing agent for myelomonocytic leukemic cells and could be potential treating compound in other type of leukemic cell differentiation.